Search Results for: Virus

10800 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ILF3 and EIF2AK2 interleukin enhancer binding factor 3 eukaryotic translation initiation factor 2 alpha kinase 2
  • ISG15 antiviral mechanism
  • Inhibition of PKR
INSR and SRC insulin receptor SRC proto-oncogene, non-receptor tyrosine kinase
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • IRS activation
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Signaling by Insulin receptor
  • Insulin receptor recycling
  • Signaling by ERBB2
  • Nuclear signaling by ERBB4
  • Downregulation of ERBB4 signaling
  • PIP3 activates AKT signaling
  • GAB1 signalosome
  • Downstream signal transduction
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Netrin mediated repulsion signals
  • Regulation of commissural axon pathfinding by SLIT and ROBO
  • RAF activation
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • MET activates PTK2 signaling
  • InlA-mediated entry of Listeria monocytogenes into host cells
  • Regulation of RUNX1 Expression and Activity
  • RUNX2 regulates osteoblast differentiation
  • Regulation of RUNX3 expression and activity
  • Extra-nuclear estrogen signaling
  • Activated NTRK2 signals through FYN
  • Activated NTRK3 signals through PI3K
  • Activated NTRK3 signals through PI3K
  • Long-term potentiation
  • Signaling downstream of RAS mutants
  • Insulin Human
  • Insulin Lispro
  • Insulin Glargine
  • Insulin Pork
  • Mecasermin
  • Insulin Aspart
  • Insulin Detemir
  • Insulin Glulisine
  • Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
  • NN344
  • AT1391
  • [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
  • Chromic chloride
  • Insulin Degludec
  • Brigatinib
  • Dasatinib
  • RU84687
  • RU79256
  • N6-Benzyl Adenosine-5'-Diphosphate
  • RU85493
  • RU78262
  • Phosphonotyrosine
  • Malonic acid
  • RU83876
  • RU90395
  • RU79072
  • RU78783
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • PASBN
  • RU82129
  • PAS219
  • DPI59
  • RU82197
  • Phenylphosphate
  • RU78300
  • RU79073
  • RU82209
  • ISO24
  • RU85053
  • RU78299
  • Oxalic Acid
  • RU78191
  • Citric Acid
  • RU81843
  • 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
  • Purvalanol A
  • XL228
  • Bosutinib
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
  • 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
  • N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
  • (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
  • Ponatinib
  • Nintedanib
  • Rabson-Mendenhall syndrome
  • Leprechaunism ; Donohue syndrome
INSR and IRF7 insulin receptor interferon regulatory factor 7
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • IRS activation
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Signaling by Insulin receptor
  • Insulin receptor recycling
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • Insulin Human
  • Insulin Lispro
  • Insulin Glargine
  • Insulin Pork
  • Mecasermin
  • Insulin Aspart
  • Insulin Detemir
  • Insulin Glulisine
  • Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
  • NN344
  • AT1391
  • [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
  • Chromic chloride
  • Insulin Degludec
  • Brigatinib
  • Rabson-Mendenhall syndrome
  • Leprechaunism ; Donohue syndrome
INSR and PTPRC insulin receptor protein tyrosine phosphatase receptor type C
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • IRS activation
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Signaling by Insulin receptor
  • Insulin receptor recycling
  • Phosphorylation of CD3 and TCR zeta chains
  • Other semaphorin interactions
  • Neutrophil degranulation
  • Insulin Human
  • Insulin Lispro
  • Insulin Glargine
  • Insulin Pork
  • Mecasermin
  • Insulin Aspart
  • Insulin Detemir
  • Insulin Glulisine
  • Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
  • NN344
  • AT1391
  • [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID
  • Chromic chloride
  • Insulin Degludec
  • Brigatinib
  • Rabson-Mendenhall syndrome
  • Leprechaunism ; Donohue syndrome
  • T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCID; Janus kinase-3 (Jak3) deficiency; IL-7 receptor alpha (IL7R alpha) deficiency; IL-2 receptor alpha (IL2R alpha) deficiency; CD45 deficiency; CD3 deficiency; Winged Helix Nude (WHN) deficiency; Immunodeficiency with thynoma
IRF1 and IRF9 interferon regulatory factor 1 interferon regulatory factor 9
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
IRF1 and TRAF3 interferon regulatory factor 1 TNF receptor associated factor 3
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • TRAF3 deficiency - HSE
  • TNFR2 non-canonical NF-kB pathway
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Ovarian tumor domain proteases
  • TICAM1-dependent activation of IRF3/IRF7
  • TRAF3-dependent IRF activation pathway
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
IRF1 and IRF2 interferon regulatory factor 1 interferon regulatory factor 2
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
IRF1 and RELA interferon regulatory factor 1 RELA proto-oncogene, NF-kB subunit
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Dimethyl fumarate
IRF1 and STAT1 interferon regulatory factor 1 signal transducer and activator of transcription 1
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Growth hormone receptor signaling
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
IRF2 and STAT1 interferon regulatory factor 2 signal transducer and activator of transcription 1
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Growth hormone receptor signaling
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
IRF2 and RELA interferon regulatory factor 2 RELA proto-oncogene, NF-kB subunit
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Dimethyl fumarate
IRF2 and ATG7 interferon regulatory factor 2 autophagy related 7
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Macroautophagy
  • Macroautophagy
  • Neutrophil degranulation
  • Signaling by BRAF and RAF fusions
  • Antigen processing: Ubiquitination & Proteasome degradation
IRF3 and IKBKE interferon regulatory factor 3 inhibitor of nuclear factor kappa B kinase subunit epsilon
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • SUMOylation of immune response proteins
  • TICAM1-dependent activation of IRF3/IRF7
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
IRF3 and TBK1 interferon regulatory factor 3 TANK binding kinase 1
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • Regulation of innate immune responses to cytosolic DNA
  • STAT6-mediated induction of chemokines
  • IRF3-mediated induction of type I IFN
  • Interleukin-37 signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
IRF3 and MAVS interferon regulatory factor 3 mitochondrial antiviral signaling protein
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Ovarian tumor domain proteases
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • Negative regulators of DDX58/IFIH1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
IRF3 and RELA interferon regulatory factor 3 RELA proto-oncogene, NF-kB subunit
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • Activation of NF-kappaB in B cells
  • RIP-mediated NFkB activation via ZBP1
  • Regulated proteolysis of p75NTR
  • Downstream TCR signaling
  • NF-kB is activated and signals survival
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • PKMTs methylate histone lysines
  • Transcriptional regulation of white adipocyte differentiation
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • Interleukin-1 processing
  • SUMOylation of immune response proteins
  • IkBA variant leads to EDA-ID
  • Dectin-1 mediated noncanonical NF-kB signaling
  • CLEC7A (Dectin-1) signaling
  • CD209 (DC-SIGN) signaling
  • CLEC7A/inflammasome pathway
  • The NLRP3 inflammasome
  • Transcriptional Regulation by VENTX
  • Interleukin-1 signaling
  • TRAF6 mediated NF-kB activation
  • Purinergic signaling in leishmaniasis infection
  • Dimethyl fumarate
IRF3 and IRF5 interferon regulatory factor 3 interferon regulatory factor 5
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • Interferon gamma signaling
  • Interferon alpha/beta signaling
IRF3 and IRF7 interferon regulatory factor 3 interferon regulatory factor 7
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
IRF3 and TICAM1 interferon regulatory factor 3 toll like receptor adaptor molecule 1
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • Caspase activation via Death Receptors in the presence of ligand
  • MyD88-independent TLR4 cascade
  • Toll Like Receptor 3 (TLR3) Cascade
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • TRIF-mediated programmed cell death
  • TICAM1 deficiency - HSE
  • TRAF3 deficiency - HSE
  • TLR3-mediated TICAM1-dependent programmed cell death
  • TICAM1-dependent activation of IRF3/IRF7
  • TICAM1,TRAF6-dependent induction of TAK1 complex
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • IKK complex recruitment mediated by RIP1
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
IRF3 and HERC5 interferon regulatory factor 3 HECT and RLD domain containing E3 ubiquitin protein ligase 5
  • ISG15 antiviral mechanism
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • Interferon gamma signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • Interferon alpha/beta signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • ISG15 antiviral mechanism
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Negative regulators of DDX58/IFIH1 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation

Page 19 out of 540 pages